AARTIPHARM evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-08-25T23:17:17.859031+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 18194425000.0
- net_income
- 1747073000.0
- operating_cash_flow
- 2619315000.0
- free_cash_flow
- -1863818000.0
- total_assets
- 34817059000.0
- total_liabilities
- 13571012000.0
- total_equity
- 21246047000.0
- cash
- 96159000.0
- total_debt
- 7543613000.0
- revenue_growth
- -0.1397738406011778
- earnings_growth
- -0.3586482323365814
- net_margin
- 0.09602243544382413
- roe
- 0.08223049680724137
- debt_to_equity
- 0.35505960238156303
- cash_conversion
- 1.499259046416492
- free_cash_flow_margin
- -0.10243896138514957
- trailing_pe
- 35.5815
- forward_pe
- 0.0
- peg_ratio
- Not supplied
- price_to_book
- 2.9273
- dividend_yield
- 0.0
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-8e30210ff66d465fcf69ac0007b436096e5d0e740393858ae437991f26428b30
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 493effd19e5c9f67a0aff9e228d8a1097c249f1692f2f881325e70745cd599c7
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: d7d4c41e818a89c053dec70f8c8db23b1cb364b0f35d16a506e79e97d3e5f920
- daily-price: c17cc675201fcaa0ba9f96b371bfaed135defcd489a4a51bf836e622db9d871a
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Evidence briefing
The local language model selected and grouped the following supplied facts.
Overview
Price source verification: VERIFIED. The trailing 5-session price return was 3.67%. The trailing 20-session price return was 11.96%. The trailing 60-session price return was 41.49%. The trailing 250-session price return was 18.08%. Average cached traded value over twenty sessions was INR 765,376,569.
Risks
The cached financial metric revenue growth is -0.1397738406011778. The cached financial metric free cash flow margin is -0.10243896138514957. The closing price was -0.44% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.
Follow Up
The cached financial metric latest annual period is 2026-03-31. The cached financial metric net margin is 0.09602243544382413. The cached financial metric roe is 0.08223049680724137. The cached financial metric debt to equity is 0.35505960238156303. The cached financial metric cash conversion is 1.499259046416492.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 968.50.
- The trailing 5-session price return was 3.67%.
- The trailing 20-session price return was 11.96%.
- The trailing 60-session price return was 41.49%.
- The trailing 250-session price return was 18.08%.
- Average cached traded value over twenty sessions was INR 765,376,569.
- The closing price was -0.44% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-08-25T23:17:17.859031+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is -0.1397738406011778.
- The cached financial metric net margin is 0.09602243544382413.
- The cached financial metric roe is 0.08223049680724137.
- The cached financial metric debt to equity is 0.35505960238156303.
- The cached financial metric cash conversion is 1.499259046416492.
- The cached financial metric free cash flow margin is -0.10243896138514957.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.